Search

Author/Creator Pordy, Robert

1. A randomized study investigating the safety, tolerability, and pharmacokinetics of evinacumab, an ANGPTL3 inhibitor, in healthy Japanese and Caucasian subjects. (December 2020)

Authors:
Harada-Shiba, Mariko; Ali, Shazia; Gipe, Daniel A.; Gasparino, Evelyn; Son, Vladimir; Zhang, Yi; Pordy, Robert; Catapano, Alberico L.
Journal:
Atherosclerosis
Issue:
Volume 314(2020)
Page Start:
33
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Alirocumab after acute coronary syndrome in patients with a history of heart failure. (18th December 2021)

Authors:
White, Harvey D; Schwartz, Gregory G; Szarek, Michael; Bhatt, Deepak L; Bittner, Vera A; Chiang, Chern-En; Diaz, Rafael; Goodman, Shaun G; Jukema, Johan Wouter; Loy, Megan; Pagidipati, Neha; Pordy, Robert; Ristić, Arsen D; Zeiher, Andreas M; Wojdyla, Daniel M; Steg, Philippe Gabriel
Journal:
European heart journal
Issue:
Volume 43:Number 16(2022)
Page Start:
1554
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Alirocumab Treatment and Achievement of Non‐High‐Density Lipoprotein Cholesterol and Apolipoprotein B Goals in Patients With Hypercholesterolemia: Pooled Results From 10 Phase 3 ODYSSEY Trials. Issue 8 (August 2017)

Authors:
Bays, Harold E.; Leiter, Lawrence A.; Colhoun, Helen M.; Thompson, Desmond; Bessac, Laurence; Pordy, Robert; Toth, Peter P.
Journal:
Journal of the American Heart Association
Issue:
Volume 6:Issue 8(2017)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Alirocumab Treatment and Achievement of Non‐High‐Density Lipoprotein Cholesterol and Apolipoprotein B Goals in Patients With Hypercholesterolemia: Pooled Results From 10 Phase 3 ODYSSEY Trials. Issue 8 (8th August 2017)

Authors:
Bays, Harold E.; Leiter, Lawrence A.; Colhoun, Helen M.; Thompson, Desmond; Bessac, Laurence; Pordy, Robert; Toth, Peter P.
Journal:
Journal of the American Heart Association
Issue:
Volume 6:Issue 8(2017)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Alirocumab treatment and neurocognitive function according to the CANTAB scale in patients at increased cardiovascular risk: A prospective, randomized, placebo-controlled study. (August 2021)

Authors:
Janik, Matthew J.; Urbach, Dorothea V.; van Nieuwenhuizen, Elane; Zhao, Jian; Yellin, Ori; Baccara-Dinet, Marie T.; Pordy, Robert; Manvelian, Garen
Journal:
Atherosclerosis
Issue:
Volume 331(2021)
Page Start:
20
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab. Issue 9 (30th June 2022)

Authors:
Hagström, Emil; Steg, P. Gabriel; Szarek, Michael; Bhatt, Deepak L.; Bittner, Vera A.; Danchin, Nicolas; Diaz, Rafael; Goodman, Shaun G.; Harrington, Robert A.; Jukema, J. Wouter; Liberopoulos, Evangelos; Marx, Nikolaus; McGinniss, Jennifer; Manvelian, Garen; Pordy, Robert; Scemama, Michel; White...
Other Names:
Schwartz Gregory G. author non-byline.; Bhatt Deepak L. author non-byline.; Bittner Vera A. author non-byline.; Diaz Rafael author non-byline.; Goodman Shaun G. author non-byline.; Harrington Robert A. author non-byline.; Jukema J. Wouter author non-byline.; Szarek Michael author non-byline.; Whi...
Journal:
Circulation
Issue:
Volume 146:Issue 9(2022)
Page Start:
657
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control. (September 2019)

Authors:
Vallejo-Vaz, Antonio J.; Ray, Kausik K.; Ginsberg, Henry N.; Davidson, Michael H.; Eckel, Robert H.; Lee, L. Veronica; Bessac, Laurence; Pordy, Robert; Letierce, Alexia; Cannon, Christopher P.
Journal:
Atherosclerosis
Issue:
Volume 288(2019)
Page Start:
85
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis. (16th November 2019)

Authors:
Sinnaeve, Peter R; Schwartz, Gregory G; Wojdyla, Daniel M; Alings, Marco; Bhatt, Deepak L; Bittner, Vera A; Chiang, Chern-En; Correa Flores, Roger M; Diaz, Rafael; Dorobantu, Maria; Goodman, Shaun G; Jukema, J Wouter; Kim, Yong-Un; Pordy, Robert; Roe, Matthew T; Sy, Rody G; Szarek, Michael; White...
Journal:
European heart journal
Issue:
Volume 41:Number 24(2020)
Page Start:
2248
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial. (21st August 2020)

Authors:
Tuñón, José; Steg, Philippe Gabriel; Bhatt, Deepak L; Bittner, Vera A; Díaz, Rafael; Goodman, Shaun G; Jukema, J Wouter; Kim, Yong-Un; Li, Qian H; Mueller, Christian; Parkhomenko, Alexander; Pordy, Robert; Sritara, Piyamitr; Szarek, Michael; White, Harvey D; Zeiher, Andreas M; Schwartz, Gregory G
Journal:
European heart journal
Issue:
Volume 41:Number 42(2020)
Page Start:
4114
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES. Issue 25 (17th December 2019)

Authors:
Jukema, J. Wouter; Zijlstra, Laurien E.; Bhatt, Deepak L.; Bittner, Vera A.; Diaz, Rafael; Drexel, Heinz; Goodman, Shaun G.; Kim, Yong-Un; Pordy, Robert; Reiner, Željko; Roe, Matthew T.; Tse, Hung-Fat; Montenegro Valdovinos, Pablo Carlos; White, Harvey D.; Zeiher, Andreas M.; Szarek, Michael; Sch...
Journal:
Circulation
Issue:
Volume 140:Issue 25(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗